Opus Genetics, Inc. Litigation Settlement, Amount (Deprecated 2017-01-31)
Opus Genetics, Inc. (IRD) had Litigation Settlement, Amount (Deprecated 2017-01-31) of JPY 210.00 million as of 2016-12-19, per its 10-K filed 2018-03-09.
Discontinued › Notes › Commitment and Contingencies
us-gaap:LitigationSettlementAmount · last filed 2018-03-09
- 2016-12-19: Litigation Settlement, Amount (Deprecated 2017-01-31) 210.00M JPY.
JPY
| Period end | Litigation Settlement, Amount (Deprecated 2017-01-31) |
|---|---|
| 2016-12-19 | 210.00M JPY 10-K · filed 2018-03-09 |
USD
| Period end | Litigation Settlement, Amount (Deprecated 2017-01-31) | Litigation Settlement, Amount (Deprecated 2017-01-31) 3 month | Litigation Settlement, Amount (Deprecated 2017-01-31) 6 month | Litigation Settlement, Amount (Deprecated 2017-01-31) 9 month | Litigation Settlement, Amount (Deprecated 2017-01-31) 12 month |
|---|---|---|---|---|---|
| 2016-12-19 | $1.77M 10-K · filed 2018-03-09 | ||||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-21 | $0.00 derived: sum of 2 quarters · filed 2014-03-21 | $100.00K 10-K · filed 2014-03-21 | ||
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13 | $100.00K 10-Q · filed 2013-11-13 | |||
| 2013-06-30 | $100.00K 10-Q · filed 2013-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |